In this second of two parts of the NEXT NORMAL, we continue our conversation with Professor Nikolai Petrovksy – the director of endocrinology at flinders medical centre with a conjoint position as professor of medicine at flinders university in Adelaide, Australia.
He and his team of international researchers are on the forefront of the effort to develop a vaccine against the novel coronavirus that causes COVID-19.
Petrovsky says he is "excited" by the vaccine test results from a colony of monkeys. It's a major step forward in the development in the fight against COVID-19 and he says it could mean human trials will begin before mid-summer.
Petrovsky’s team is an international coalition of public and private sector contributors and none of them is pursuing this vaccine for profit.
It may prove to be the NEXT NORMAL in vaccine research and development. Petrovsky says “I think (governments and public health authorities) are going to be amazed that this model actually does work….and I hope then that governments and global corporations realize this is the model of the future. It’s not massive pharma companies that take years to deliver and consume billions of dollars in doing so. If you can have a small, highly mobile, very fast team doing this hundreds of thousands or a few million dollars and deliver and even better product faster, why are you investing billions in these big corporations that really are dinosaurs when it comes to dealing with a pandemic.”
He expects there will be more than one successful vaccine in relatively short order. But the challenge will be effectively distributing doses around the world in a short period of time.